Travere Therapeutics Inc（TVTX）— 同業公司組
數據截至2026-10-28 — 評分每個交易日晚間重新計算。分組標準＝首先為共同的Closelook指數成分，其次為產業。Closelook研究日記，不構成投資建議。
Travere Therapeutics Inc的Closelook綜合評分為42/100，在同業公司組內排名第7位（共7家）——組內評分最高的是BB Biotech AG（74/100）。
| 名稱 | 綜合 | 動能 | 品質 | 估值 | 訊號 | 距52週高點 |
|---|---|---|---|---|---|---|
| TVTX Travere Therapeutics Inc | 42 | 61 | 28 | 10 | info | 26% |
| BION.SW BB Biotech AG | 74 | 67 | 96 | 81 | info | 11.9% |
| HALO Halozyme Therapeutics Inc | 73 | 98 | 94 | 38 | ok | 0.2% |
| UCB.BR UCB SA | 65 | 66 | 70 | 53 | info | 6.1% |
| ARGX.BR Argen-X | 64 | 75 | 75 | 29 | info | 13.9% |
| ONC BeiGene, Ltd. | 64 | 85 | 64 | 30 | ok | 3.9% |
| ARGX argenx NV ADR | 63 | 69 | 74 | 28 | info | 16.9% |
FAQ · from the current data · as of 2026-10-28
Quick answers
Travere Therapeutics Inc在Closelook涵蓋範圍內的同業公司有哪些？
分組首先根據共同的Closelook指數成分，其次根據產業：BB Biotech AG (BION.SW)、Halozyme Therapeutics Inc (HALO)、UCB SA (UCB.BR)、Argen-X (ARGX.BR)、BeiGene, Ltd. (ONC)、argenx NV ADR (ARGX)。
TVTX相對同業公司的評分如何？
Travere Therapeutics Inc的綜合評分為42/100，組內排名第7位（共7家），截至2026-10-28；組內最高綜合評分為BB Biotech AG（74/100）。Closelook評分為研究日記讀數，不構成評等或投資建議。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- HALO Halozyme Therapeutics Incindustry
- UCB.BR UCB SAindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- ARGX argenx NV ADRindustry
- KOD Kodiak Sciences Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- IOVA Iovance Biotherapeutics Incindustry
- FTRE Fortrea Holdings Inc.industry
- ABSI Absci Corpindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- REPL Replimune Group Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- MRNA Moderna Incindustry
- RXRX Recursion Pharmaceuticals Incindustry
- XNCR Xencor Incindustry
- IRON Disc Medicine Inc.industry
- LEGN Legend Biotech Corpindustry
- BHVN Biohaven Ltd.industry